| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 94,876 | 95,442 | 68,164 | 80,630 |
| Cost of sales - product | 14,403 | 14,035 | 13,769 | 13,084 |
| Research and development | 19,116 | 16,619 | 19,377 | 14,403 |
| Selling, general and administrative | 40,086 | 50,359 | 47,678 | 43,061 |
| Bad debt expense | 0 | 0 | 10,970 | - |
| Total operating expenses | 73,605 | 81,013 | 91,794 | 70,548 |
| Income (loss) from operations | 21,271 | 14,429 | -23,630 | 10,082 |
| Interest income | 6,593 | 6,798 | 7,739 | 9,382 |
| Interest expense | 1,643 | 1,641 | 1,692 | 1,699 |
| Sublease income | 2,225 | 2,226 | 2,226 | 2,205 |
| Loss on debt extinguishment | 0 | 0 | -82,095 | - |
| Other loss | -27 | -596 | -423 | -152 |
| Net income (loss) before income taxes | 28,419 | 21,216 | -97,875 | 19,818 |
| Provision for income taxes | 1,492 | 2,495 | -1,776 | 2,224 |
| Net income (loss) | 26,927 | 18,721 | -96,099 | 17,594 |
| Basic (in shares) | 117,307,000 | 119,317,000 | 124,871,000 | 131,133,000 |
| Basic (in usd per share) | 0.23 | 0.16 | -0.77 | 0.13 |
| Diluted (in shares) | 136,468,000 | 138,356,000 | 124,871,000 | 154,807,000 |
| Diluted (in usd per share) | 0.21 | 0.14 | -0.77 | 0.12 |
DYNAVAX TECHNOLOGIES CORP (DVAX)
DYNAVAX TECHNOLOGIES CORP (DVAX)